This strategic move is intended to streamline Mankind Pharma’s operations, enabling greater focus on its core pharmaceutical business.
With this capital infusion, the airline plans to boost its operations, improve its fleet, and expand its network to satisfy rising passenger demand.
The strategic partnership aims to enhance Bajaj Healthcare's presence in the European pharmaceutical market.
This positive outcome indicates compliance with FDA standards and enhances Glenmark's credibility in the pharmaceutical sector.
Manba Finance has successfully raised ₹45.25 Crore from eight institutional investors, allocating 3,771,000 shares at ₹120 each.
In conclusion, the US Food and Drug Administration (USFDA) has issued Form 483 with no observations.
The total investment for these capacity expansions amounted to ₹58 Crore. The company received operational consent from relevant authorities for the enhancements.
The company also recently announced that it had received a 500 MW battery storage contract through the Solar Energy Corporation of India's e-reverse auction (eRA).
ATGL aims to support India’s transition to a gas-based economy through this infrastructure development.
This inspection success at Bachupally, combined with steady financial performance, reinforces Dr Reddy's position as a key player in the pharmaceutical industry.

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.